| Long-term safety of sorafenib in advanced renal cell carcinoma: Follow-up of ... - UroToday |
|
|
UroTodayThe phase III Treatment Approaches in Renal cancer Global Evaluation Trial (TARGET) indicated that sorafenib is effective and well tolerated in advanced ... read more |